America leads the world in healthcare innovation and providing patients the highest quality of care. Unfortunately, since the passage of the Affordable Care Act (ACA), we have seen higher premiums, larger deductibles, and fewer choices for patients. While many have greater access to insurance through the health exchanges, this coverage does not truly equal care. Americans deserve a path forward that makes the highest quality healthcare affordable to all Americans. This includes making prescription drugs more affordable, covering those with pre-existing conditions, giving families greater choice and flexibility in purchasing coverage that best fits their need, and supporting research and development of treatments and cures. You may be interested to know some of the following legislative actions I’ve taken in this regard:
- Chair of the House Lung Cancer Caucus, Chair of the House Crohn’s and Colitis Caucus, member of the Rare Disease Caucus, and member of the Congressional Alzheimer’s Caucus
- Supported H.R. 19, the Lower Costs, More Cures Act, a bipartisan proposal to lower prescription drug costs that caps seniors’ out-of-pocket drug costs, lowers the cost of insulin, encourages innovation in developing new cures and treatments, and gives patients greater transparency of their treatment options.
- Worked to guarantee coverage for individuals with pre-existing conditions, even if the Affordable Care Act is overturned in the courts, by cosponsoring H.R. 4159, the Ensuring Coverage for Patients with Pre-Existing Conditions Act, and H.R. 692, the Pre-existing Conditions Protection Act of 2019.
- Advocated for H.R. 1034, the Phair Pricing Act, to increase prescription drug price transparency at the point-of-sale.
- Cosponsored H.R. 2279, the Safe Step Act, which gives doctors and patients greater choice when prescribing medications.
- Fought to increase funding for research and development of treatments and cures for Alzheimer’s and dementia.
- Worked to improve access to new therapies for neurodegenerative diseases like ALS through H.R. 7071, the Accelerating Access to Critical Therapies for ALS Act.
- Cosponsored H.R. 2222, a bipartisan bill to expand awareness, education, and research on the disparate impact of lung cancer on women.
- Supported H.R.4439, the Creating Hope Reauthorization Act, to expedite FDA approval of treatments for rare pediatric diseases, which recently passed the House with bipartisan support.
More on Health Care
WASHINGTON, D.C. – President Trump has signed into law the Crisis Stabilization and Community Reentry Act of 2020, a bill introduced in the House by Representative John Rutherford (R-FL) and Representative David Trone (D-MD). This new law expands access to mental health services for individuals leaving the prison system, providing a “Continuity of Care” for those at risk of recidivism.
WASHINGTON, D.C. – Today, Congressmen John Rutherford (FL-04) and Brendan F. Boyle (PA-02), bipartisan co-chairs of the Congressional Lung Cancer Caucus, introduced legislation to designate November as Lung Cancer Awareness Month. While Lung Cancer Awareness Month has traditionally taken place in November, this legislation in Congress would formally recognize its observance during that month.
After a brief pause due to the Coronavirus, I'm happy to say my “Rutherford Ride Alongs” are back! Today I visited Standard Feed & Seed in Northeast Florida to learn more about their day-to-day operations and the challenges they face as a growing business. For the past 73 years, Standard Feed & Seed has provided our community with assistance in gardening, raising livestock and chickens, and taking care of household pets.
WASHINGTON, D.C. – Congressman John Rutherford (FL-04) is now an original cosponsor of the COVID-19 Accountability Act. This legislation, introduced by Representative Doug Collins (R-GA), would grant authority to the president to place sanctions on the Chinese Communist Party if they do not cooperate with an investigation into the origins of the COVID-19 outbreak.
WASHINGTON, D.C. – Today, Congressman John Rutherford (FL-04) applauds the House passage of H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act. This bipartisan legislation is the third economic assistance package approved by Congress to maintain stability and fight the COVID-19 pandemic.
WASHINGTON, D.C. – Today, U.S. Representatives John Rutherford (FL-04), Derek Kilmer (WA-06), and Jaime Herrera Beutler (WA-03) introduced H.R. 6207, the Coronavirus Worker Relief Act.
WASHINGTON, D.C. – Today, the House of Representatives voted to approve H.R. 6, the SUPPORT for Patients and Communities Act, a House-Senate package of bills to combat the opioid crisis. This measure supports ongoing efforts to bolster treatment and recovery, enhance preventative measures, and give law enforcement the tools needed to get drugs off the street.
WASHINGTON, D.C. – Today, the House of Representatives passed H.R. 6157, legislation that allocates funding to the Departments of Defense, Labor, Health and Human Services, and Education for Fiscal Year (FY) 2019. The measure, which passed the Senate last week, now heads to the President’s desk to be signed into law. Upon passage of the bill, Congressman John Rutherford released the following statement:
Today, Rep. John Rutherford voted in support of H.R. 36, the Pain Capable Unborn Child Protection Act which passed the House on a 237-189 vote. The Pain-Capable Unborn Child Protection Act restricts abortions beyond 20 weeks fertilization, the gestational age when unborn children begin to feel pain. Specifically, H.R. 36 establishes criminal penalties for any person who performs or attempts an abortion on a fetus after the 20-week mark, with exceptions for saving the life of the mother or for cases of rape or incest.